Annual EBITDA
-$125.94 M
+$88.63 M+41.30%
31 December 2023
Summary:
Praxis Precision Medicines annual earnings before interest, taxes, depreciation & amortization is currently -$125.94 million, with the most recent change of +$88.63 million (+41.30%) on 31 December 2023. During the last 3 years, it has fallen by -$64.02 million (-103.40%). PRAX annual EBITDA is now -379.34% below its all-time high of -$26.27 million, reached on 31 December 2018.PRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$56.74 M
-$19.36 M-51.80%
30 September 2024
Summary:
Praxis Precision Medicines quarterly earnings before interest, taxes, depreciation & amortization is currently -$56.74 million, with the most recent change of -$19.36 million (-51.80%) on 30 September 2024. Over the past year, it has dropped by -$31.34 million (-123.34%). PRAX quarterly EBITDA is now -658.19% below its all-time high of -$7.48 million, reached on 31 December 2019.PRAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$163.59 M
-$31.34 M-23.69%
30 September 2024
Summary:
Praxis Precision Medicines TTM earnings before interest, taxes, depreciation & amortization is currently -$163.59 million, with the most recent change of -$31.34 million (-23.69%) on 30 September 2024. Over the past year, it has dropped by -$24.00 million (-17.19%). PRAX TTM EBITDA is now -1436.95% below its all-time high of -$10.64 million, reached on 30 September 2019.PRAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRAX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.3% | -123.3% | -17.2% |
| 3 y3 years | -103.4% | -26.9% | -21.8% |
| 5 y5 years | -379.3% | -433.1% | -1437.0% |
PRAX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -103.4% | +41.3% | -123.3% | +17.5% | -29.9% | +29.6% |
| 5 y | 5 years | -379.3% | +41.3% | -658.2% | +17.5% | -1437.0% | +29.6% |
| alltime | all time | -379.3% | +41.3% | -658.2% | +17.5% | -1437.0% | +29.6% |
Praxis Precision Medicines EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$56.74 M(+51.8%) | -$163.59 M(+23.7%) |
| June 2024 | - | -$37.38 M(-10.5%) | -$132.26 M(+1.9%) |
| Mar 2024 | - | -$41.77 M(+50.8%) | -$129.73 M(+3.0%) |
| Dec 2023 | -$125.94 M(-41.3%) | -$27.70 M(+9.0%) | -$125.94 M(-9.8%) |
| Sept 2023 | - | -$25.41 M(-27.1%) | -$139.59 M(-11.9%) |
| June 2023 | - | -$34.85 M(-8.2%) | -$158.38 M(-13.8%) |
| Mar 2023 | - | -$37.98 M(-8.1%) | -$183.80 M(-14.3%) |
| Dec 2022 | -$214.57 M(+28.4%) | -$41.35 M(-6.4%) | -$214.57 M(-7.4%) |
| Sept 2022 | - | -$44.19 M(-26.7%) | -$231.78 M(-0.2%) |
| June 2022 | - | -$60.27 M(-12.3%) | -$232.33 M(+11.4%) |
| Mar 2022 | - | -$68.76 M(+17.4%) | -$208.51 M(+24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$167.15 M(+170.0%) | -$58.56 M(+30.9%) | -$167.15 M(+24.5%) |
| Sept 2021 | - | -$44.73 M(+22.7%) | -$134.28 M(+27.0%) |
| June 2021 | - | -$36.46 M(+33.1%) | -$105.75 M(+30.8%) |
| Mar 2021 | - | -$27.40 M(+6.6%) | -$80.86 M(+30.6%) |
| Dec 2020 | -$61.92 M(+73.2%) | -$25.69 M(+58.5%) | -$61.92 M(+41.7%) |
| Sept 2020 | - | -$16.21 M(+40.2%) | -$43.71 M(+14.6%) |
| June 2020 | - | -$11.56 M(+36.7%) | -$38.15 M(+43.5%) |
| Mar 2020 | - | -$8.46 M(+13.0%) | -$26.59 M(+46.7%) |
| Dec 2019 | -$35.75 M(+36.1%) | -$7.48 M(-29.7%) | -$18.13 M(+70.3%) |
| Sept 2019 | - | -$10.64 M | -$10.64 M |
| Dec 2018 | -$26.27 M | - | - |
FAQ
- What is Praxis Precision Medicines annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual EBITDA year-on-year change?
- What is Praxis Precision Medicines quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly EBITDA year-on-year change?
- What is Praxis Precision Medicines TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Praxis Precision Medicines?
- What is Praxis Precision Medicines TTM EBITDA year-on-year change?
What is Praxis Precision Medicines annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PRAX is -$125.94 M
What is the all time high annual EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual earnings before interest, taxes, depreciation & amortization is -$26.27 M
What is Praxis Precision Medicines annual EBITDA year-on-year change?
Over the past year, PRAX annual earnings before interest, taxes, depreciation & amortization has changed by +$88.63 M (+41.30%)
What is Praxis Precision Medicines quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PRAX is -$56.74 M
What is the all time high quarterly EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$7.48 M
What is Praxis Precision Medicines quarterly EBITDA year-on-year change?
Over the past year, PRAX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$31.34 M (-123.34%)
What is Praxis Precision Medicines TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PRAX is -$163.59 M
What is the all time high TTM EBITDA for Praxis Precision Medicines?
Praxis Precision Medicines all-time high TTM earnings before interest, taxes, depreciation & amortization is -$10.64 M
What is Praxis Precision Medicines TTM EBITDA year-on-year change?
Over the past year, PRAX TTM earnings before interest, taxes, depreciation & amortization has changed by -$24.00 M (-17.19%)